Orphan Drugs Market 2021-2026 PDF: Revenue Estimations, Size, Share and Segments

1. Global Orphan Drugs Market Research and Upcoming Forecast Report Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Orphan Drugs Market Outlook 2026: IMARC Group’s latest report, titled “Orphan Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” finds that the global orphan drugs market size exhibited a strong growth Orphan drugs refer to medications that are intended for diagnosing, preventing and treating rare, life- threatening diseases or disorders. As they traditionally had a limited market, very few pharmaceutical companies pursued research into these products. Moreover, orphan drug research is dependent on government incentives. However, the growing number of rare diseases lacking treatment, along with improving access to healthcare and spending capacity of individuals, has led to a significant rise in the demand for orphan drugs. Request for a free sample report: https://www.imarcgroup.com/orphan-drugs-market/requestsample

4. Report Description and Highlights Report Description Global Orphan Drugs Market Trends: At present, incentives for drug development provided by government authorities in various countries are encouraging pharmaceutical companies to develop orphan drugs. For instance, the United States Food and Drug Administration (USFDA) offers benefits such as fast-track approval, protocol assistance, waiver of fees and marketing exclusivity to manufacturers, facilitating the development and commercialization of diagnostic tools and treatments devoted to rare diseases. Furthermore, there has been a rise in the development of orphan biological drugs that can prevent or treat various forms of cancer, tumors and blood disorders, which, in turn, is contributing to the market growth. In 2019, the Center for Drug Evaluation and Research (CDER), a division of the USFDA, approved various new orphan drug therapies for patients with numerous disorders, including tenosynovial giant cell tumor, sickle cell disease, diffuse large B-cell lymphoma, mantle cell lymphoma, acquired thrombotic thrombocytopenic purpura, beta-thalassemia, and acute hepatic porphyria. Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).

5. Report Description and Highlights Report Description Market Breakup by Drug Type: • Biological • Non-Biological Market Breakup by Disease Type: • Oncology • Hematology • Neurology • Cardiovascular • Others Market Breakup by Phase: • Phase I • Phase II • Phase III • Phase IV

6. Report Description and Highlights Report Description Market Breakup by Top Selling Drugs: • Revlimid • Rituxan • Copaxone • Opdivo • Keytruda • Imbruvica • Avonex • Sensipar • Soliris • Others Market Breakup by Distribution Channel: • Hospital Pharmacies • Retail Pharmacies • Online Stores • Others

7. Report Description and Highlights Report Description Market Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others

8. Report Description and Highlights Report Description •Latin America • • • •Middle East and Africa Brazil Mexico Others Note: We are updating our research report 2021-2026. If you want to need latest primary and secondary data with Cost Module, Business Strategy, Distribution Channel, etc.

9. Report Description and Highlights Report Description Competitive Landscape With Key Players: • AbbVie Inc. • Alexion Pharmaceuticals Inc. • Amgen Inc. • Biogen Inc. • Bristol-Myers Squibb Company. • F. Hoffmann-La Roche AG. • Roche Holding AG. • Jazz Pharmaceuticals Plc. • Johnson & Johnson. • Merck & Co. Inc. • Novartis AG. • Pfizer Inc. • Sanofi S.A. • Takeda Pharmaceutical Company Limited • Teva Pharmaceutical Industries Ltd View Report TOC, Figures and Tables : https://www.imarcgroup.com/orphan-drugs-market

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com